Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “RFS”

31 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 31 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT07328828
What this trial is testing

Single-Arm Clinical Study of Icaritin Soft Capsules as Adjuvant Therapy for Hepatocellular Carcinoma Patients at High Risk of Postoperative Recurrence

Who this might be right for
RFS
Second Affiliated Hospital, Zhejiang University, School of Medicine 20
Testing effectiveness (Phase 2)Study completedNCT00006026
What this trial is testing

Nitrocamptothecin in Treating Patients With Metastatic Cancer of the Urinary Tract

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer
European Organisation for Research and Treatment of Cancer - EORTC 21
Not applicableLooking for participantsNCT06314958
What this trial is testing

Stage II/III Colorectal Cancer Recurrence

Who this might be right for
Colorectal CancerColorectal AdenocarcinomaColorectal Cancer Stage II+2 more
City of Hope Medical Center 400
Testing effectiveness (Phase 2)Study completedNCT00005874
What this trial is testing

Nitrocamptothecin in Treating Patients With Soft Tissue Sarcomas

Who this might be right for
Gastrointestinal Stromal TumorSarcomaSmall Intestine Cancer
Astex Pharmaceuticals, Inc.
Testing effectiveness (Phase 2)Study completedNCT00005875
What this trial is testing

Nitrocamptothecin in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
Astex Pharmaceuticals, Inc.
Testing effectiveness (Phase 2)UnknownNCT00005877
What this trial is testing

Nitrocamptothecin in Treating Patients With Advanced or Recurrent Colorectal Cancer

Who this might be right for
Colorectal Cancer
Astex Pharmaceuticals, Inc.
Large-scale testing (Phase 3)UnknownNCT00005869
What this trial is testing

Nitrocamptothecin Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Astex Pharmaceuticals, Inc.
Testing effectiveness (Phase 2)Looking for participantsNCT06910813
What this trial is testing

DFT383 in Pediatric Participants With Nephropathic Cystinosis

Who this might be right for
Nephropathic Cystinosis
Novartis Pharmaceuticals 30
Not applicableStudy completedNCT02829086
What this trial is testing

Evaluation of the Refugee Family Strengthening (RFS) Program

Who this might be right for
Health Behavior
US Committee for Refugees and Immigrants 5,365
Large-scale testing (Phase 3)Looking for participantsNCT06644937
What this trial is testing

Single-arm Clinical Trial of TACE in Combination With Icaritin as Adjuvant Therapy After Surgery in Patients With Hepatocellular Carcinoma at High Risk of Recurrence

Who this might be right for
Hepatocellular Carcinoma (HCC)
Zhujiang Hospital 30
Large-scale testing (Phase 3)Ended earlyNCT00113256
What this trial is testing

Orathecin + Gemcitabine Versus Placebo + Gemcitabine in Chemonaive Non-Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Astex Pharmaceuticals, Inc. 39
Large-scale testing (Phase 3)UnknownNCT00005870
What this trial is testing

Nitrocamptothecin Compared With Other Chemotherapy in Treating Patients With Recurrent or Refractory Cancer of the Pancreas

Who this might be right for
Pancreatic Cancer
Astex Pharmaceuticals, Inc.
Not applicableStudy completedNCT05307926
What this trial is testing

Postoperative Adjuvant Therapy of HCC Based on PD-1

Who this might be right for
Hepatocellular CarcinomaRFS
Chen Xiaoping 573
Post-approval studies (Phase 4)UnknownNCT03253250
What this trial is testing

The Investigation of Peginterferon Alfa-2a on the RFS of the Subjects With HCC Who Have Been Treated by Resection

Who this might be right for
Chronic Hepatitis bHepatic Carcinoma
Huashan Hospital 432
Large-scale testing (Phase 3)UnknownNCT00005871
What this trial is testing

Nitrocamptothecin or Fluorouracil in Treating Patients With Recurrent or Refractory Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Astex Pharmaceuticals, Inc.
Testing effectiveness (Phase 2)Study completedNCT00005872
What this trial is testing

Nitrocamptothecin in Treating Patients With Recurrent Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Astex Pharmaceuticals, Inc.
Not applicableEnded earlyNCT01079598
What this trial is testing

RFS (Radiofrequency Stylet) - Radiofrequency Perforator Vein Treatment Study

Who this might be right for
Venous Insufficiency
Medtronic Endovascular 8
Not applicableUnknownNCT01565486
What this trial is testing

Safety and Efficacy Study of Ultrasonic Coagulation Device and Bipolar Energy Sealing System

Who this might be right for
Thyroid Cancer
Seoul St. Mary's Hospital 304
Not applicableWithdrawnNCT02837523
What this trial is testing

Biomarker for Cystinosis Disease: BioCystinosis (BioCystinosis)

Who this might be right for
Renal Fanconi SyndromePhotophobiaHypophosphatemia
CENTOGENE GmbH Rostock
Testing effectiveness (Phase 2)Study completedNCT00006082
What this trial is testing

Nitrocamptothecin in Treating Patients With Advanced Small Cell Lung Cancer

Who this might be right for
Lung Cancer
European Organisation for Research and Treatment of Cancer - EORTC 38
Next Page